Getting the Best Medical Care: a Newsletter from Patrick Malone - December 2013

In This Issue:

- Who Takes Statins and Why

- Evidence Tells the Truth

- The Risk Calculator

- Statin Side Effects

- What Should You Do?

- Excerpt from Introduction:

Spotlight on Statins: The Controversy Over New Drug Guidelines:

Last month, in an effort to lower the rate of heart attacks and strokes in the U.S., the American Heart Association (AHA) and the American College of Cardiology (ACC) revised the guidelines for prescribing statins, drugs that impair the body's ability to create cholesterol.

The revision focused on preventing a cardiac event among people who have never had one. The panel that composed the guidelines moved away from trying to reach a certain level of blood cholesterol and toward lowering one's overall risk of heart disease and stroke. Defined by risk factors established by the panel, moving the goal froma number to a behavior includes substantially increasing how many people would take statins...

Please see full newsletter below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Patrick Malone & Associates P.C. | DC Injury Lawyers | Attorney Advertising

Written by:


Patrick Malone & Associates P.C. | DC Injury Lawyers on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.